Fed Circ upholds Teva cancer drug patents

17-08-2021

Alex Baldwin

Fed Circ upholds Teva cancer drug patents

Ralf Liebhold / Shutterstock.com

The US Court of Appeals for the Federal Circuit has affirmed a Delaware court ruling upholding the validity of cancer drug patents owned by Teva Pharmaceuticals.


US Court of Appeals for the Federal Circuit, Teva Pharmaceuticals, Eagle Pharmaceuticals, generics

LSIPR